Page URL:

Paralysed mice walk after stem cell injections

21 September 2005
By BioNews
Appeared in BioNews 327

US scientists have used nerve stem cells to treat mice affected by severe spinal cord injuries. The team, based at the University of California at Irvine, said the treated animals regained the ability to walk just a few weeks after receiving the injections. The findings, published in the Proceedings of the National Academy of Sciences, add to growing evidence that stem cells from a variety of sources could lead to new therapies for spinal cord injuries and diseases.

The researchers used nerve stem cells obtained from 16-18 week-old aborted human fetuses. They injected mice with around 75,000 of these cells, at four sites surrounding the injury. After nine days, the treated animals were more mobile, and a few weeks later they could walk again. Microscope analysis revealed that the injected cells had turned into both neurons (nerve cells), and also new oligodendrocytes - cells that produce the protective substance myelin, which protects and insulates nerve cells.

Study author Brian Cummings said the team were 'excited to find that the cells responded to the damage by making appropriate new cells that could assist in repair', adding 'this study supports the possibility that formation of new neurons may contribute to recovery'. To check whether the cell injections really were linked to the improvement of the mice, the scientists gave some of the recovering animals a toxin that kills human cells. The walking ability of the mice given the toxin regressed again, whilst those spared the treatment continued to improve.

The company that supplied the cells used in the study, StemCells Inc, is one of three US firms who say they are close to testing human neural stem cells as therapies, according to a report in the Washington Post. Earlier this year, another team at the University of California at Irvine successfully treated rats with spinal cord injuries, using cells derived from human embryonic stem cells (ES cells) by Geron. And unpublished research shows that human fetal spinal cord cells developed by NeuralStem Inc can also help repair spinal cord damage in rats. All three companies hope to obtain permission from the US Food and Drug Administration to begin testing their cells in humans, perhaps as early as next year.

Human neural stem cells significantly improved mobility in paralyzed mice
Medical News Today |  20 September 2005
Stem Cell Injections Repair Spinal Cord Injuries in Mice
The Washington Post |  20 September 2005
Stem cells bridge spinal cord gap
The Globe and Mail |  19 September 2005
22 April 2013 - by Matthew Young 
A neural stem cell therapy aimed at treating the symptoms of amyotrophic lateral sclerosis (ALS) is set to advance in the USA, after the Food and Drug Administration (FDA) gave its approval for it to proceed to the next stage of clinical trials...
2 April 2012 - by Dr Linda Wijlaars 
A clinical trial to test the safety of a stem cell treatment for amyotrophic lateral sclerosis, the most common form of motor neurone disease, suggests that the new therapy is safe and well-tolerated. Encouragingly, one of the 12 patients participating in the study showed some improvement, although the trial was not designed to test the treatment's efficacy...
28 September 2009 - by Dr Marianne Kennedy 
The US Food and Drug Administration (FDA) has granted approval to NeuralStem Inc., a Maryland-based biotherapeutics company, to conduct the first human trial using neural stem cells for treatment of amyotrophic lateral sclerosis (ALS). ALS is a type of motor neuron disease often referred to as 'Lou Gehrig's' and 'Maladie de Charcot'. The late-onset condition, of unknown cause, affects approximately two in 100,000 people, including the UK physicist Stephen Hawking and US rock gui...
22 September 2008 - by Alison Cranage 
Researchers have generated a specialised type of nerve cell - astrocytes - from embryonic stem (ES) cells. The astrocytes were used to treat spinal injury in rats, with impressive results, restoring their ability to move freely. The team of scientists from the University of Rochester, New York, and the...
23 October 2006 - by Dr Jess Buxton 
A new study carried out on rats shows that injections of human embryonic stem (ES) cells can relieve the symptoms of Parkinson's disease (PD) - but the treatment also produces potentially cancerous cells, say US researchers. A team based at Cornell University Medical College in New York...
13 May 2005 - by BioNews 
US scientists have successfully treated rats with spinal cord injuries, using cells derived from human embryonic stem (ES) cells. The team, based at the Reeve-Irvine Research Center at the University of California, Irvine, reports that the cells restored movement in rats treated seven days after the initial injury, but did...
4 July 2003 - by BioNews 
Two new studies carried out using rats have shown that stem cells taken from early embryos could be used to treat spinal injuries. Researchers at the University of California in Irvine, US, used stem cells from human embryos to grow specialised 'nerve insulating' cells to successfully treat paralysed rats with...
30 May 2000 - by BioNews 
A team of researchers at Washington University School of Medicine, St Louis, has grown nerve cells in the laboratory and used them to repair damaged adult rat spinal cords. The scientists used embryo stem cells - cells that can grow into any type of body tissue - to obtain a supply of...
to add a Comment.

By posting a comment you agree to abide by the BioNews terms and conditions

Syndicate this story - click here to enquire about using this story.